These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 1100711)
41. Treatment of experimental salmonellosis in mice with streptomycin entrapped in liposomes. Tadakuma T; Ikewaki N; Yasuda T; Tsutsumi M; Saito S; Saito K Antimicrob Agents Chemother; 1985 Jul; 28(1):28-32. PubMed ID: 3899004 [TBL] [Abstract][Full Text] [Related]
42. The use of live attenuated Salmonella for oral vaccination. Chatfield S; Roberts M; Li J; Starns A; Dougan G Dev Biol Stand; 1994; 82():35-42. PubMed ID: 7958481 [TBL] [Abstract][Full Text] [Related]
43. Vaccination against typhoid fever with a live oral vaccine. Germanier R Dev Biol Stand; 1976; 33():85-8. PubMed ID: 782975 [TBL] [Abstract][Full Text] [Related]
44. Insertion of a 59 amino acid peptide in Salmonella Typhimurium membrane results in loss of virulence in mice. Porta A; Morello S; Granata I; Iannone R; Maresca B FEBS J; 2014 Nov; 281(22):5043-53. PubMed ID: 25208333 [TBL] [Abstract][Full Text] [Related]
45. Flagellar phase variation of Salmonella enterica serovar Typhimurium contributes to virulence in the murine typhoid infection model but does not influence Salmonella-induced enteropathogenesis. Ikeda JS; Schmitt CK; Darnell SC; Watson PR; Bispham J; Wallis TS; Weinstein DL; Metcalf ES; Adams P; O'Connor CD; O'Brien AD Infect Immun; 2001 May; 69(5):3021-30. PubMed ID: 11292720 [TBL] [Abstract][Full Text] [Related]
46. An attenuated Salmonella enterica serovar Typhimurium strain lacking the ZnuABC transporter induces protection in a mouse intestinal model of Salmonella infection. Pesciaroli M; Aloisio F; Ammendola S; Pistoia C; Petrucci P; Tarantino M; Francia M; Battistoni A; Pasquali P Vaccine; 2011 Feb; 29(9):1783-90. PubMed ID: 21219981 [TBL] [Abstract][Full Text] [Related]
47. [The biological properties and virulence of a lysogenic strain from an SM-resistant strain of Mycobacterium tuberculosis]. Nakano H; Sushida K Kekkaku; 1985 Nov; 60(11):577-84. PubMed ID: 3937930 [No Abstract] [Full Text] [Related]
48. Basic Processes in Diard M; Hardt WD Microbiol Spectr; 2017 Sep; 5(5):. PubMed ID: 28884670 [TBL] [Abstract][Full Text] [Related]
49. Development of an Avirulent Salmonella Surrogate for Modeling Pathogen Behavior in Pre- and Postharvest Environments. de Moraes MH; Chapin TK; Ginn A; Wright AC; Parker K; Hoffman C; Pascual DW; Danyluk MD; Teplitski M Appl Environ Microbiol; 2016 Jul; 82(14):4100-4111. PubMed ID: 27129962 [TBL] [Abstract][Full Text] [Related]
50. Salmonella enterica serovar Typhimurium pathogenicity island 2 is necessary for complete virulence in a mouse model of infectious enterocolitis. Coburn B; Li Y; Owen D; Vallance BA; Finlay BB Infect Immun; 2005 Jun; 73(6):3219-27. PubMed ID: 15908346 [TBL] [Abstract][Full Text] [Related]
51. Efficacy of a novel virulence gene-deleted Salmonella Typhimurium vaccine for protection against Salmonella infections in growing piglets. Hur J; Song SO; Lim JS; Chung IK; Lee JH Vet Immunol Immunopathol; 2011 Feb; 139(2-4):250-6. PubMed ID: 20869776 [TBL] [Abstract][Full Text] [Related]
52. Rewiring of one carbon metabolism in Salmonella serves as an excellent live vaccine against systemic salmonellosis. Datey A; Shreenivas M; Chandrasekharan G; Joseph J; Sah S; Aluri S; Saha S; Varshney U; Chakravortty D Vaccine; 2018 Nov; 36(50):7715-7727. PubMed ID: 30385055 [TBL] [Abstract][Full Text] [Related]
53. [Transduction analysis of the virulence of revertants of streptomycin-dependent mutants of S. enteritidis]. Shuster BIu; Likhoded VG; Sergeev VV; Elkina SI; Limarev VA Zh Mikrobiol Epidemiol Immunobiol; 1971 Dec; 48(12):58-62. PubMed ID: 4943709 [No Abstract] [Full Text] [Related]
54. Salmonella typhimurium DT104: a virulent and drug-resistant pathogen. Poppe C; Smart N; Khakhria R; Johnson W; Spika J; Prescott J Can Vet J; 1998 Sep; 39(9):559-65. PubMed ID: 9752592 [TBL] [Abstract][Full Text] [Related]
55. Monoclonal antibodies to Salmonella lipopolysaccharide: anti-O-polysaccharide antibodies protect C3H mice against challenge with virulent Salmonella typhimurium. Colwell DE; Michalek SM; Briles DE; Jirillo E; McGhee JR J Immunol; 1984 Aug; 133(2):950-7. PubMed ID: 6203984 [TBL] [Abstract][Full Text] [Related]
56. The effect of streptomycin resistance, caffeine and acriflavine on ultraviolet light-induced reversion to tryptophan independence in strains of Escherichia coli B/r. Barfknecht TR; Shankel DM Mutat Res; 1975 Nov; 30(2):163-76. PubMed ID: 1107829 [TBL] [Abstract][Full Text] [Related]
57. A multi-drug resistant Salmonella Typhimurium ST213 human-invasive strain (33676) containing the bla CMY-2 gene on an IncF plasmid is attenuated for virulence in BALB/c mice. Wiesner M; Calva JJ; Bustamante VH; Pérez-Morales D; Fernández-Mora M; Calva E; Silva C BMC Microbiol; 2016 Feb; 16():18. PubMed ID: 26862033 [TBL] [Abstract][Full Text] [Related]
58. Evaluation of efficacy of a new live Salmonella Typhimurium vaccine candidate in a murine model. Hur J; Kim MY; Lee JH Comp Immunol Microbiol Infect Dis; 2011 Mar; 34(2):171-7. PubMed ID: 21111480 [TBL] [Abstract][Full Text] [Related]
59. [Pathogenic and immunogenic properties of a streptomycin dependent mutant of Salmonella gaertneri]. Sergeev VV; Taratorina OM; Elkina SI Zh Mikrobiol Epidemiol Immunobiol; 1967 Aug; 44(8):56-60. PubMed ID: 5616881 [No Abstract] [Full Text] [Related]